About the Forum:
About the Forum
Overview
Executive Committee
Executive Committee Log-on
Sponsors
Staff
Special Events
Special Announcements
Join Our E-Mail Service
Support the Forum
Employment and Internship Opportunities
Biomedical Prevention Information Page
Forum News
Past Projects | Current Projects | Publications & Reports | Links | Past Events
Overview of Projects
ARV Drugs, Adverse Events, Case Definition, Grading, Laboratory Diagnosis and Treatment Monitoring
Roundtable: Maximizing Opportunities for HIV Diagnosis and Prevention in the U.S.A.
Meeting the Demand for Male Circumcision: An assessment of what is needed
Biomedical Interventions for HIV Prevention
Chemokine Antagonist Working Group
HCV Drug Resistance Advisory Group
HIV-TB Co-Infection: Meeting the Challenge
HIV and TB
Long-Term Monitoring of Treatment Related Adverse Events in the Resource Limited Setting
Pediatric Diagnosis and Monitoring Working Group
Rethinking the Approach to Expanded Access Programs
Re-thinking the Design of Clinical Trials for the Development of New ARVS for Treatment Experienced and Treatment Naïve Patient Population
Standardization and Clinical Relevance of HIV Drug Resistance Testing
Statistical and Epidemiology Issues in HIV Research
Transfer of HIV Diagnostic and Monitoring Technologies into Resource-Poor Settings
Workshop on Quantitative Methods for Research on Antiviral Resistance
International Public Health Dialogue on HIV Testing and Counselling
HIV-TB Fact Sheet
Collaborative Approaches to HIV Drug Development: Planning for Long-Term Monitoring of Safety in CCR5 Antagonist Development. Report of a Joint FDA/FCHR Joint Public Meeting
HIV and TB in the Context of Universal Access: What is Working and what is not?
Description of HIV Cohorts & Databases
Resistance Analysis Collaboration
July 28, 2008
January 8, 2008
Media Coverage from the November 2, 2007 Press Release
November 2, 2007
June 14, 2007
February 23, 2007
